Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

IQVIA Holdings, Inc. Common Stock (NY: IQV )

196.78 -1.19 (-0.60%)
Streaming Delayed Price Updated: 2:08 PM EST, Jan 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 Next >
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Forecasting The Future: 8 Analyst Projections For IQVIA Hldgs
Via Benzinga
IQV Stock Earnings: IQVIA Hldgs Beats EPS, Beats Revenue for Q1 2024
IQV stock results show that IQVIA Hldgs beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Analysts Are Pounding the Table on These 3 Stocks: April 2024
From pharmaceutical testing to expansive integration expanding infrastructure, here are three stocks with analyst recommendations to buy. 
Via InvestorPlace
Salesforce & IQVIA Expand Partnership: Life Sciences Cloud Gets A Superpower Boost
Salesforce shares rise after partnership with IQVIA to develop Life Sciences Cloud for customer engagement. 
Via Benzinga
Peering Into IQVIA Hldgs's Recent Short Interest
Via Benzinga
Peering Into IQVIA Hldgs's Recent Short Interest
Via Benzinga
How Is The Market Feeling About IQVIA Hldgs?
Via Benzinga
Earnings Scheduled For February 14, 2024
Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on revenue of $24.62 billion. 
Via Benzinga
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while. 
Via The Motley Fool
Stocks Rebound As Investor Focus Shifts To Earnings, Bitcoin Tops $1 Trillion Value: What's Driving Markets Wednesday?
The U.S. stock market attempted a rebound following Tuesday’s declines, which were sparked by a higher-than-expected inflation report in January, as investors refocused on corporate earnings. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Healthcare Analytics-Focused IQVIA Says 2023 Performance Solid Despite Challenging Macro Environment
IQVIA beats Q4 2023 sales expectations, reporting $3.87 billion (3.5% Y/Y). Adjusted EPS of $2.84 exceeds guidance. IQV's 2023 performance and optimistic 2024 outlook. 
Via Benzinga
Peeling Back The Layers: Exploring IQVIA Hldgs Through Analyst Insights
Via Benzinga
Expert Ratings For IQVIA Hldgs
Via Benzinga
(IQV) - Analyzing IQVIA Hldgs's Short Interest
Via Benzinga
IQVIA Hldgs Stock: A Deep Dive Into Analyst Perspectives (11 Ratings)
Via Benzinga
Charles River Laboratories International Posts Upbeat Results, Joins Robinhood, Zillow, Tower Semiconductor And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Wednesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names
Biotech is one of the areas of interest in the market today, adding a biotech stock could be huge play this month. 
Via InvestorPlace
IQVIA's Bold Merger Move Blocked As FTC's Concerns Over Competition Take Center Stage
IQVIA Holdings, Inc.'s (NYSE: IQV) attempt to acquire DeepIntent, a healthcare advertising firm, was reportedly thwarted as a U.S. 
Via Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
Via Benzinga
How Is The Market Feeling About IQVIA Hldgs?
Via Benzinga
$1000 Invested In IQVIA Hldgs 5 Years Ago Would Be Worth This Much Today
Via Benzinga
The Latest Analyst Ratings for IQVIA Hldgs
Via Benzinga
Looking Into IQVIA Hldgs's Recent Short Interest
Via Benzinga
Price Over Earnings Overview: IQVIA Hldgs
Via Benzinga
Analyst Ratings for IQVIA Hldgs
Via Benzinga
Peering Into IQVIA Hldgs's Recent Short Interest
Via Benzinga
The Latest Analyst Ratings for IQVIA Hldgs
Via Benzinga
Healthcare Analytics Solutions Provider IQVIA Cuts Annual Forecast, Sees Demand Slowing For Services
IQVIA Holdings Inc (NYSE: IQV) reported Q3 sales of $3.74 billion, up 4.9% Y/Y on a reported basis and 4.1% at constant currency (CC),  
Via Benzinga
The Latest Analyst Ratings for IQVIA Hldgs
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.